Living With Lyme: A Cannabis Consumer's Practical Guide

Cannabinoid and Terpene Protocols for Post-Treatment Lyme Disease Syndrome (PTLDS)

Post-Treatment Lyme Disease Syndrome (PTLDS) involves a physiological state where the immune system remains in a loop of hyper-arousal after Borrelia burgdorferi has been addressed. This chronic release of pro-inflammatory cytokines may keep the body in a defensive posture. Because the Endocannabinoid System (ECS) acts as a primary homeostatic regulator, it can become exhausted by the demands of persistent infection. Supplementing with exogenous cannabinoids may provide the ECS with the components to support systemic balance.

Managing the Jarisch-Herxheimer (Herx) Reaction

The Herxheimer reaction is the body’s systemic response to endotoxins released during bacterial die-off. As these toxins affect the system, inflammation may rise and metabolic stress may intensify.

• CBD (Cannabidiol): CBD acts as an anti-inflammatory agent. By inhibiting cytokine production, it may help dampen the internal inflammation associated with a Herx flare-up.
• Beta-Caryophyllene: This sesquiterpene functions as a CB2 receptor agonist. It provides neuroprotective effects while supporting the liver and kidneys as they filter circulating toxins.

Technical Dosing: The 3-Tier Strategy

Lyme symptoms vary based on bacterial load and inflammatory cycles. A tiered approach may allow for a steady baseline while providing tools for acute flare-ups.

Tier 1: The Anti-Inflammatory Foundation

The goal is a consistent plasma concentration to prevent inflammatory spikes.

• Protocol: 25–50mg of Full-Spectrum CBD every 12 hours.
• CBG (Cannabigerol) Integration: Consider adding 10–20mg of CBG. By targeting the GPR55 receptor, CBG may support muscle spasticity and gut-level inflammation often seen in Bartonella co-infections.

Tier 2: Daytime Cognitive Support

Brain fog in PTLDS is often rooted in neuroinflammation and neurotransmitter dysregulation.

• Protocol: 1–2.5mg of THC (via tincture or vaporization).
• Terpene Selection:
  • Pinene: Acts as an acetylcholinesterase inhibitor, which may slow the breakdown of acetylcholine in the brain. This can provide support for memory retention and mental sharpness.
  • Limonene: This may help modulate dopamine and serotonin levels without the sedative effects associated with other terpenes.

Tier 3: Restorative Nocturnal Recovery

Healing often requires deep sleep, which is frequently interrupted by neuropathic painsomnia.

• Protocol: A 1:1 ratio of THC to CBN (Cannabinol).
• Mechanism: CBN, a degraded metabolite of THC, has a sedative affinity. This combination is designed to reduce sleep latency and help keep the nervous system grounded.

Neurological Symptom Management

Lyme bacteria are neurotropic, meaning they may affect the central and peripheral nervous systems.

• Neuropathic Pain: When nerve sheaths are inflamed, the synergy between THC and CBD can be beneficial. THC may modulate pain signals at the spinal cord level, while CBD may address the physical inflammation of the nerve tissue.
• Cognitive Dysfunction: Terpene profiling can be a resource for neural symptoms. Terpinolene may help calm the "over-wired" sensation associated with neuro-Lyme, while Myrcene acts as a penetration enhancer, increasing the permeability of the blood-brain barrier to assist cannabinoids in reaching the CNS.

Pharmacological Safety and Interactions

The metabolic profile of a Lyme patient requires caution.

• The CYP450 Interaction: High-dose CBD inhibits CYP450 enzymes in the liver, which are responsible for metabolizing many antibiotics and antimalarials. To prevent potential toxicity or reduced efficacy of prescribed medications, space out cannabis use by at least two hours.
• Tachycardia and POTS: Many PTLDS patients experience Postural Orthostatic Tachycardia Syndrome (POTS). Note that THC is a vasodilator. If heart rate instability is a concern, keep formulations CBD-dominant (aim for at least a 10:1 ratio) to avoid triggering a cardiovascular stress response.
• Localized Relief: For joint stiffness and localized pain, prioritize high-potency CBD/THC transdermal salves. By bypassing systemic metabolism, these may provide direct, targeted relief to inflamed connective tissue without taxing the liver.

---

Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.

Sources

1. Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. (2009). Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 1(7):1333-49. PubMed

2. Russo EB. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 163(7):1344-64. PubMed

3. Bento AF, Marcon R, Dutra RC, Claudino RF, Cola M, Leite DF, Calixto JB. (2011). β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway. Am J Pathol. 178(3):1153-66. PubMed

4. Mlost J, Bryk M, Starowicz K. (2020). Cannabidiol for pain treatment: focus on pharmacology and mechanism of action. Int J Mol Sci. 21(22):8870. PubMed

5. Kaplan JS, Stella N, Catterall WA, Bhatt DL. (2017). Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proc Natl Acad Sci USA. 114(42):11229-11234. PubMed